Trial | NCT03775200  Report issue

Official Title

The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    233
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression
The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression - a dose-ranging study
Study Started
Mar 01
2019
Primary Completion
Jul 30
2021
Study Completion
Sep 27
2021
Last Update
Jan 26
2022

Drug Psilocybin

Dose-ranging

Low dose Experimental

Low dose Psilocybin

Medium dose Experimental

Medium dose Psilocybin

High dose Experimental

High dose Psilocybin

Criteria 

Inclusion Criteria:

Diagnosis of TRD

Exclusion Criteria:

Other comorbidities
No Results Posted